The Netherlands-based Reyedar, a deeptech startup developing a medical tech platform for the early detection of age-related degenerative diseases, announced on Wednesday, July 5, that it has raised €3M in a fresh round of funding.
Reyedar’s deep learning and eye-tracking technologies together offer a window into the human brain and health problems, allowing for the early detection of many age-related disorders.
The round was led by Cottonwood Technology Fund, a venture capital firm that invests in early-stage technology companies. The round also saw participation from NOM, Pupil Labs, Uneti Ventures, and existing investor Blue Sparrows MedTech Fund.
Medtech startup that provides diagnostic tools
Reyedar mentions that a significant portion of the world’s population suffers from visual impairments and neurodegenerative diseases, including glaucoma, Parkinson’s disease, and multiple sclerosis, which have a negative influence on their quality of life.